

EULAR 2024 RA Topic Panel
Jun 24, 2024
Panel discussion led by rheumatology experts Drs. Aurelie Najm, David Liew, and Jonathan Kay at EULAR 2024 meeting. Topics include disappointing trial results for bio-naive patients, challenges in treatment selection, importance of addressing depression, impact of medications on vaccination responses, debate on therapeutic drug monitoring in RA treatment, and use of innovative apps for remote patient monitoring in rheumatoid arthritis.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 2min
Amplified Study in Rheumatoid Arthritis
01:32 • 7min
Debates, Disappointments, and Depression in Rheumatoid Arthritis
08:43 • 5min
Vaccination Strategies for Rheumatoid Arthritis Patients
13:35 • 17min
Predictive Biomarkers and Therapeutic Response in Early Disease
30:53 • 3min
Debate on Therapeutic Drug Monitoring in Rheumatoid Arthritis Treatment
34:21 • 3min
Innovative Apps for Remote Monitoring in Rheumatoid Arthritis
37:03 • 4min
Exploring Differentiation Between Osteoarthritis and Rheumatoid Arthritis Using Digital Tools and Study on Progression from Palindromic Rheumatism to Chronic Inflammatory Arthritis
41:27 • 4min